Glenmark pharma share price graph
GLENMARK PHARMA Share Price Today: GLENMARK PHARMA last traded price had tanked 5.4% to Rs 205.8 on the BSE. On the NSE, GLENMARK PHARMA last traded price had tanked 5.9% to Rs 205.0. The total volume of shares traded was 3.9 m. Overall, the broader S&P BSE HEALTHCARE Index was down by 0.0%. And the benchmark S&P BSE SENSEX was at 30,579.1 (down 2.6%). Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World.
The stock of Glenmark Pharmaceuticals can be bought with a target price of Rs 500 as the company continues to remain confident on achieving single-digit growth in FY20E despite a persisting decline in gMupirocin sales.
Today we are going to analyze the Glenmark Pharma Share Price Graph. Before step into the main analytical discussion, it is important to check out the company details and financial data. Let’s start with the share price of the company based on the current market scenario. As on 28.06.18 Glenmark share price stands at 577.50 in NSE. Get Live BSE/ NSE share price of Glenmark Pharma. View Glenmark Pharma historical charts, stock market reports, financial report, volume, market performance & latest news on NDTV Profit. Glenmark Pharmaceuticals Stock Forecast, "GLENMARK" Share Price Prediction Charts Is "Glenmark Pharmaceuticals Ltd" a Good Investment? Current price today: 209.450 INR (+1.972%) GLENMARK PHARMA Share Price Today: GLENMARK PHARMA last traded price had tanked 5.4% to Rs 205.8 on the BSE. On the NSE, GLENMARK PHARMA last traded price had tanked 5.9% to Rs 205.0. The total volume of shares traded was 3.9 m. Overall, the broader S&P BSE HEALTHCARE Index was down by 0.0%. And the benchmark S&P BSE SENSEX was at 30,579.1 (down 2.6%). Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019.
Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: term financial; Valuation - Attractiveness today; CFT - Current financial trend
Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns, Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Glenmark Pharmaceuticals Ltd.. From Indias independent mutual fund research Price Graph. Piramal Enterprises. Lupin. S&P BSE
Glenmark Pharmaceuticals Limited (GLENMARK.NS). NSE - NSE Real Time Price. Currency in INR.
Glenmark Pharmaceuticals Limited (GLENMARK.NS). NSE - NSE Real Time Price. Currency in INR. This page features historic data for the Glenmark Pharmaceuticals Ltd share ( GLEN) as well as the closing price, open, high, low, change and %change. Get today's Glenmark Pharmaceuticals Ltd. share price details along with futures & options quotes. Get detailed report in terms of MF holding details, financials, Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns,
Price to Book Value. 1. Below industry median. Corporate actions: Split history for Glenmark Pharmaceuticals Ltd. Glenmark Glenmark Pharmaceuticals Ltd. had last split the face value of its shares from Rs 2 to Rs 1 in 2016.The share has
Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Glenmark Pharmaceuticals Ltd.. From Indias independent mutual fund research Price Graph. Piramal Enterprises. Lupin. S&P BSE GLENMARK Share Price Today Key Fundamentals of GLENMARK PHARMACEUTICALS. Sector We donot recomend daily/intraday minuite, hourly charts. 19 Feb 2020 The Glenmark Pharmaceuticals (NSE:GLENMARK) Share Price Is Down most people consider earnings and revenue growth trends to be a Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: term financial; Valuation - Attractiveness today; CFT - Current financial trend
2000 - The Glenmark Pharmaceutical scrip opened its innings on the Bombay Stock Exchange at Rs 550, a whopping 175 per cent increase over the issue price of Rs 200 (including a premium of Rs 190) per share. Glenmark Pharmaceuticals Ltd. share price forecast The 16 reports from 8 analysts offering long term price targets for Glenmark Pharmaceuticals Ltd. have an average target of 408.88. The consensus estimate represents an upside of 85.52% from the last price of 220.40. Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA. 16.12.2019. Glenmark Pharma receives GMP certificate from European regulator; share price gains 3%. 18.11.2019